<DOC>
	<DOCNO>NCT01964989</DOCNO>
	<brief_summary>Safety , Immunogenicity Efficacy Adjuvanted Quadrivalent Subunit Influenza Virus Vaccine Compared Non-Adjuvanted Comparator Influenza Vaccine Children ≥6 &lt; 72 Months Age .</brief_summary>
	<brief_title>Clinical Study Evaluate Safety , Immunogenicity Efficacy Investigational Flu Vaccine Compared Approved Flu Vaccine Children .</brief_title>
	<detailed_description />
	<mesh_term>Influenza , Human</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Children , males female , healthy high risk complication influenza , ≥6 month &lt; 72 month age Documented consent provide subject 's parent ( ) /legal guardian ( ) Subjects and/or subject 's parent ( ) /legal guardian ( ) able comply study procedure . Children history allergy vaccine component . Additional eligibility criterion may discuss contact site</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>72 Months</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Influenza</keyword>
	<keyword>child</keyword>
</DOC>